Matches in SemOpenAlex for { <https://semopenalex.org/work/W4214485526> ?p ?o ?g. }
- W4214485526 endingPage "116" @default.
- W4214485526 startingPage "97" @default.
- W4214485526 abstract "A model of progressively endocrine-resistant breast cancer was investigated to identify changes that can occur in signaling pathways after endocrine manipulation.The MCF7 breast cancer model is sensitive to estrogens and anti-estrogens while variant lines previously derived from wild-type MCF7 are either relatively 17β-estradiol (E2)-insensitive (LCC1) or fully resistant to estrogen and anti-estrogens (LCC9).In LCC1 and LCC9 cell lines, loss of estrogen sensitivity was accompanied by loss of growth response to transforming growth factor alpha (TGFα), heregulin-beta and pertuzumab. LCC1 and LCC9 cells had enhanced AKT phosphorylation relative to MCF7 which was reflected in downstream activation of phospho-mechanistic target of rapamycin (mTOR), phospho-S6, and phospho-estrogen receptor alpha Ser167 [ERα(Ser167)]. Both AKT2 and AKT3 were phosphorylated in the resistant cell lines, but small interfering RNA (siRNA) knockdown suggested that all three AKT isoforms contributed to growth response. ERα(Ser118) phosphorylation was increased by E2 and TGFα in MCF7, by E2 only in LCC1, but by neither in LCC9 cells. Multiple alterations in E2-mediated cell cycle control were identified in the endocrine-resistant cell lines including increased expression of MYC, cyclin A1, cyclin D1, cyclin-dependent kinase 1 (CDK1), CDK2, and hyperphosphorylated retinoblastoma protein (ppRb), whereas p21 and p27 were reduced. Estrogen modulated expression of these regulators in MCF7 and LCC1 cells but not in LCC9 cells. Seliciclib inhibited CDK2 activation in MCF7 cells but not in resistant variants; in all lines, it reduced ppRb, increased p53 associated responses including p21, p53 up-regulated modulator of apoptosis (PUMA), and p53 apoptosis-inducing protein 1 (p53AIP1), inhibited growth, and produced G2/M block and apoptosis.Multiple changes occur with progression of endocrine resistance in this model with AKT activation contributing to E2 insensitivity and loss of ERα(Ser118) phosphorylation being associated with full resistance. Cell cycle regulation is modified in endocrine-resistant breast cancer cells, and seliciclib is effective in both endocrine-sensitive and resistant diseases." @default.
- W4214485526 created "2022-03-02" @default.
- W4214485526 creator A5007286394 @default.
- W4214485526 creator A5009340780 @default.
- W4214485526 creator A5012169663 @default.
- W4214485526 creator A5012906382 @default.
- W4214485526 creator A5013140743 @default.
- W4214485526 creator A5071262153 @default.
- W4214485526 creator A5077500149 @default.
- W4214485526 creator A5089893713 @default.
- W4214485526 creator A5091690433 @default.
- W4214485526 date "2022-02-28" @default.
- W4214485526 modified "2023-10-09" @default.
- W4214485526 title "Collateral-resistance to estrogen and HER-activated growth is associated with modified AKT, ERα, and cell-cycle signaling in a breast cancer model" @default.
- W4214485526 cites W11697548 @default.
- W4214485526 cites W1494515794 @default.
- W4214485526 cites W1502739652 @default.
- W4214485526 cites W1596758412 @default.
- W4214485526 cites W1615513261 @default.
- W4214485526 cites W1671912264 @default.
- W4214485526 cites W1828378256 @default.
- W4214485526 cites W1918570764 @default.
- W4214485526 cites W1964578073 @default.
- W4214485526 cites W1965326552 @default.
- W4214485526 cites W1966129042 @default.
- W4214485526 cites W1968858823 @default.
- W4214485526 cites W1981800752 @default.
- W4214485526 cites W1983788571 @default.
- W4214485526 cites W1984746631 @default.
- W4214485526 cites W1985453548 @default.
- W4214485526 cites W1997006452 @default.
- W4214485526 cites W1997053696 @default.
- W4214485526 cites W2014457594 @default.
- W4214485526 cites W2016569614 @default.
- W4214485526 cites W2025005089 @default.
- W4214485526 cites W2026493214 @default.
- W4214485526 cites W2027542963 @default.
- W4214485526 cites W2030678473 @default.
- W4214485526 cites W2031399699 @default.
- W4214485526 cites W2033344337 @default.
- W4214485526 cites W2039771541 @default.
- W4214485526 cites W2040611519 @default.
- W4214485526 cites W2069359520 @default.
- W4214485526 cites W2072787342 @default.
- W4214485526 cites W2080780583 @default.
- W4214485526 cites W2083280703 @default.
- W4214485526 cites W2083516264 @default.
- W4214485526 cites W2089020917 @default.
- W4214485526 cites W2096946707 @default.
- W4214485526 cites W2099647354 @default.
- W4214485526 cites W2110917779 @default.
- W4214485526 cites W2112986537 @default.
- W4214485526 cites W2116703074 @default.
- W4214485526 cites W2117357260 @default.
- W4214485526 cites W2127997722 @default.
- W4214485526 cites W2134299232 @default.
- W4214485526 cites W2139818579 @default.
- W4214485526 cites W2141232624 @default.
- W4214485526 cites W2142095017 @default.
- W4214485526 cites W2147934525 @default.
- W4214485526 cites W2150043577 @default.
- W4214485526 cites W2150081723 @default.
- W4214485526 cites W2152856165 @default.
- W4214485526 cites W2154472114 @default.
- W4214485526 cites W2157023753 @default.
- W4214485526 cites W2161151817 @default.
- W4214485526 cites W2161762726 @default.
- W4214485526 cites W2161770000 @default.
- W4214485526 cites W2162114545 @default.
- W4214485526 cites W2162344195 @default.
- W4214485526 cites W2165957980 @default.
- W4214485526 cites W2278019288 @default.
- W4214485526 cites W2318725321 @default.
- W4214485526 cites W2502967437 @default.
- W4214485526 cites W2808838194 @default.
- W4214485526 cites W2944883972 @default.
- W4214485526 cites W2990256362 @default.
- W4214485526 cites W3015634062 @default.
- W4214485526 cites W3045863217 @default.
- W4214485526 cites W3083198770 @default.
- W4214485526 doi "https://doi.org/10.37349/etat.2022.00074" @default.
- W4214485526 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35441158" @default.
- W4214485526 hasPublicationYear "2022" @default.
- W4214485526 type Work @default.
- W4214485526 citedByCount "0" @default.
- W4214485526 crossrefType "journal-article" @default.
- W4214485526 hasAuthorship W4214485526A5007286394 @default.
- W4214485526 hasAuthorship W4214485526A5009340780 @default.
- W4214485526 hasAuthorship W4214485526A5012169663 @default.
- W4214485526 hasAuthorship W4214485526A5012906382 @default.
- W4214485526 hasAuthorship W4214485526A5013140743 @default.
- W4214485526 hasAuthorship W4214485526A5071262153 @default.
- W4214485526 hasAuthorship W4214485526A5077500149 @default.
- W4214485526 hasAuthorship W4214485526A5089893713 @default.
- W4214485526 hasAuthorship W4214485526A5091690433 @default.
- W4214485526 hasBestOaLocation W42144855261 @default.
- W4214485526 hasConcept C121608353 @default.
- W4214485526 hasConcept C126322002 @default.